This meeting took place June 10-12, 2011 in Vancouver, BC. The official homepage for the meeting includes a link to many of the official abstracts to the papers that I discuss in this blog. You can also access a flash-based fully interactive program for the meeting and the Canadian Glaucoma Society portion of the meeting. This blog consits of editorialized articles highlighting the glaucoma related material that was presented at the meeting based on notes that I wrote at the time. Please come back regularly or subsribe to the RSS feed to see the articles as they appear and please add to the discussion so that we can all continue to learn from this material.
Dr Eytan Blumenthal, one of our invited speakers, prepared an entertaining and thought provoking talk about glaucoma surgery and the cocept of feedback loops. Writing an article about his talk is akin to dancing about architecture. Nonetheless, here are my notes and thoughts about his lecture.
With no new classes of glaucoma medications since 1996, there is increased focus on preservatives and whether they are toxic. Is this as bad as the buzz on the street?
BAK, HTM, Trabecular Meshwork, preservatives, toxicity in Glaucoma Generally medical first line therapy but risk early failure from med Tx. Is it the med or preservative that is the culprit? Benzalkonium Chloride (BAK) is a detergent that does cause conjunctival metaplasia. The purpose of this study was to identify if BAK causes poorer glaucoma surgical outcomes based on a retrospective review.
BAK, preservatives, surgery, toxicity in Glaucoma Prevalence of glaucoma increasing due to aging of the population. Angle closure more likely to lead to blindness. ACG more common in Asia and in the Inuit population. As for INCIDENCE data, which is needed to plan for our care needs, but much harder to do.
Are disc heme’s glaucoma’s HgB A1C? You are only checking your patient’s 1/10,000 of the time even if you see your patient every 3 months. So only a fraction of their time. Does ODH predict damage in the future?
